Katja Hatz
9PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 15, 2026
Lower Rates of Intraocular Inflammation with Aflibercept 8 mg Delivered via Pre-Filled Syringe Versus Vial.Laura Hoffmann, Katja Hatz
|Jan 30, 2026
First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report.Amr Saad, Christina Plasencia, Justus Garweg
|Sep 26, 2025
Irvine-Gass Syndrome Personalized Treatment Outcomes: A Retrospective Single-Center Cohort Study.Lorenzo Tomaschek, Laura Hoffmann, Robert Katamay
|Apr 12, 2025
Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration.Katja Hatz, Aude Ambresin, Martin Schmid
|Sep 28, 2024
Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study.Ferhat Turgut, Gábor M Somfai, Christoph Tappeiner
|May 16, 2023
Prospective Study Comparing Quantitative Self-Monitoring Metamorphopsia Measurement Tools in Myopic Choroidal Neovascularization (mCNV).Laura Hoffmann, Susanne Müller, Lucas M Bachmann
Pageof 2
Frequent Collaborators
2 joint publications
Gabor Mark Somfai
2 joint publications
Isabel Barbara Pfister
1 joint publications
Ursula Margarethe Schmidt-Erfurth
1 joint publications
Bianca S Gerendas
1 joint publications
Albert J Augustin
1 joint publications
Matthias D Becker
1 joint publications
Hakan Kaymak
1 joint publications
Ferhat Turgut
1 joint publications
Christoph Tappeiner
1 joint publications
Guy Donati
